Phesi
Phesi provides comprehensive clinical development analytical products and services for biopharmaceutical companies around the world. Its integrated offerings cover the entire clinical development process – from development planning and indication assessment to protocol evaluation, site selection and trial implementation management.
Latest Phesi Content
Product News
New Phesi Proof of Concept Demonstrates Potential of AI-Powered Digital Twins To Replace External Control Arms in Clinical Trials
Study published in Bone Marrow Transplantation uses real-world clinical data to create virtual digital twin cohorts instead of placebo and standard-of-care comparator arms.
Product News
Phesi Launches Predictive Patient Burden Score To Improve Trial Efficiency, Patient Experience and Investigator Site Performance
Latest real-world metric in Phesi’s AI-driven Trial Accelerator™ quantifies patient burden to unlock a patient-centric approach to trial design and implementation.
Product News
Phesi Launches Health Check and Trial Rescue Service To Save At-Risk Trials and Bring Drugs to Market Faster
New free of charge service will offer insights in under ten days to sponsors conducting clinical trials in any indication, identifying potential “zombie trials” and providing actionable recommendations for failing trials.
Industry Insight
Digital Twins and Trial Arms: Is the Future of Single-Arm Oncology Trials Already Here?
In this opinion piece, Dr. Gen Li discusses how AI and predictive analytics are transforming oncology clinical trials.
Advertisement
